Evidence map›Paper›PMID 40748896›Full record

ArticlePloS one2025

Genotype distribution of human papillomavirus among women with cervical cancer stratified by HIV status in Tanzania.

Alita Mrema, Mamsau Ngoma, Emmanuel L Lugina, Atukuzwe Kahakwa, Chacha Josiah Mwita, Salama Iddy, Eulade Rugengamizi, Kandali Samwel, John Ngowi, Salum J Lidenge and 2 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alita MremaDepartment of Clinical Research Training and Consultancy, Ocean Road Cancer Institute, Dar es salaam, Tanzania.
Mamsau NgomaDepartment of Clinical Research Training and Consultancy, Ocean Road Cancer Institute, Dar es salaam, Tanzania.
Emmanuel L LuginaDepartment of Clinical Research Training and Consultancy, Ocean Road Cancer Institute, Dar es salaam, Tanzania.ORCID https://orcid.org/0000-0002-9083-4302
Atukuzwe KahakwaDepartment of Clinical Oncology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Chacha Josiah MwitaDepartment of Clinical Research Training and Consultancy, Ocean Road Cancer Institute, Dar es salaam, Tanzania.
Salama IddyDepartment of Clinical Research Training and Consultancy, Ocean Road Cancer Institute, Dar es salaam, Tanzania.
Eulade RugengamiziDepartment of Oncology, Butaro Cancer Center, Burera, Rwanda.ORCID https://orcid.org/0000-0003-0385-3706
Kandali SamwelDepartment of Clinical Research Training and Consultancy, Ocean Road Cancer Institute, Dar es salaam, Tanzania.
John NgowiDepartment of Clinical Research Training and Consultancy, Ocean Road Cancer Institute, Dar es salaam, Tanzania.
Salum J LidengeDepartment of Clinical Research Training and Consultancy, Ocean Road Cancer Institute, Dar es salaam, Tanzania.
Charles WoodDepartment of Interdisciplinary Medicine, Louisiana State University Health Sciences Center- New Orleans, Louisiana, United States of America.
Julius MwaiselageDepartment of Clinical Research Training and Consultancy, Ocean Road Cancer Institute, Dar es salaam, Tanzania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCervical cancer (CC) is the leading cancer among women in Tanzania, especially among those between the ages of 15 and 44. The prevalence of high-risk Human papillomavirus (HR-HPV)-16/18 women in the general population at any given time is 3.3%. HR-HPVs 16 or 18 are the primary cause of CC. The distribution of HPV genotypes among women with CC according to HIV status is unknown in Tanzania. This study aimed to determine the HPV genotype distribution according to HIV status among women with CC in Tanzania.

methodsThis cross-sectional study was done at Ocean Road Cancer Institute (ORCI) in Tanzania among women with histologically confirmed CC. HIV serology testing was performed. Biopsy was taken from cervical lesions, and DNA was extracted. HPV DNA was amplified by using a previously validated multiplex HPV PCR assay targeting 14 high-risk HPV genotypes (16,18,30,31,33, 35, 39, 45, 51, 52, 56, 58, 59, and 66) and two low-risk HPV genotypes (6 and 11). Continuous variables were compared using either a student t-test or the Mann-Whitney U test. Fisher's exact test was employed to compare discrete variables. A P-value less than 0.05 was considered statistically significant.

resultsWe included 100 women with CC. The prevalence of HIV infection in this study was 42%. The prevalence of any HPV infection was 94%, ranging from 1-3 genotypes per woman. HPV. The median age for women living with HIV (WLWH) with CC patients was 45 years (IQR, 31-60), while the median age for HIV-uninfected women with CC patients was 57 years (IQR, 30-78). (p = 0.0001). WLWH and HIV-uninfected women had similar HPV prevalence, except for HPV 35, which was more common in WLWH. There was a trend of high prevalence of HPV 52 and HPV 58 in WLHH compared to HIV-uninfected women, but this difference was not statistically significant. The prevalence of HPV 16 and/or 18 infection in the entire sample was 85%. The combined prevalence of HPV 16 and/or 18 was 76% WLWH and 91% amongst HIV-uninfected women (p = 0.036).The majority of women (77.9%) had single-genotype HPV infection. There was no difference in the distribution of multiple or single HPV genotypes infection by HIV status (p = 0.25).

conclusionIn this study, HIV positive women with CC presented at a significantly younger age (45 years) compared to the HIV-negative women (57 years). The prevalence of high-risk HPV is high among women with CC in Tanzania. Distribution of most high-risk HPV genotypes among women with CC was not significantly influenced by HIV status except for HPV 35, which appeared to be more in HIV positive women compared to HIV-negative women. While the majority of the high-risk HPV infections were with single HPV genotypes, the prevalence of multiple high-risk HPV infections was at 22%, with no significant difference between the two HIV statuses. A vaccination program that aptly targets HPV 16 and 18 could prevent up to 85% of CC cases in Tanzania, regardless of HIV. Keywords: Human papillomavirus, cervical cancer, HIV, Tanzania.

Indexed as

HIV InfectionsPapillomaviridaePapillomavirus InfectionsUterine Cervical NeoplasmsAdolescentAdultCross-Sectional StudiesDNA, ViralFemaleGenotypeHuman Papillomavirus VirusesHumansMiddle AgedPrevalenceTanzaniaYoung AdultDNA, Viral

Identifiers

PMID40748896
PMCPMC12316304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.